Loading…
Incannex Healthcare Inc Is A Clinical-Stage Biopharmaceutical Development Company Dedicated To Developing Inventive Medicines For Patients Living With Serious Chronic Diseases And Unmet Needs. The Company'S Drug Candidates Include Ihl-42x For The Treatment Of Obstructive Sleep Apnea (Osa) And Psx-001, The Company'S Psilocybin Treatment In Combination With Psychological Therapy In Development To Treat Patients With Generalized Anxiety Disorder (Gad). The Company Also Has A Drug Candidate, Ihl-675a, For The Treatment Of Rheumatoid Arthritis. Each Of These Programs Target Conditions That Currently Have Limited, Inadequate, Or No Approved Pharmaceutical Treatment Options. The Company Continues To Evaluate Strategies For Ihl-675a When And As Resources Permit.